Linked Life Data

9292128

Source:http://linkedlifedata.com/resource/pubmed/id/9292128

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-9-25
pubmed:abstractText
Epistaxis is a common symptom in patients with hereditary haemorrhagic telangiectasia. It may vary in severity from infrequent mild bleeds to regular severe bleeding, the latter requiring multiple blood transfusions. Laser, which can be used to coagulate the telangiectasia without destroying the overlying nasal mucosa, would theoretically seem to be the ideal mode of treatment. In this pilot study, an argon laser has been used on nineteen patients with hereditary haemorrhagic telangiectasia and is shown to be beneficial in patients with mild or moderate epistaxis. Patients with severe epistaxis, or who fail argon laser treatment, are candidates for alternative therapeutic strategies such as a modified Young's procedure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-2151
pubmed:author
pubmed:issnType
Print
pubmed:volume
111
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
34-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
pubmed:affiliation
Institute of Laryngology and Otology, London, UK.
pubmed:publicationType
Journal Article